The 11th International Symposium on Targeted Alpha Therapy (TAT11) will be held in Ottawa, Canada April 1-5th 2019. TAT11 is jointly organized by Canadian Nuclear Laboratories and TRIUMF. 

Call-for-Abstracts

TAT11 invites all interested individuals to submit oral and/or poster abstracts to share the most up-to-date research and review challenging and interesting cases from around the world. 

Important Dates
Initial abstract submission DEADLINE: September 13, 2018
Author notification of abstract acceptance within four weeks of deadline